Applied DNA Sciences News

S-1: General form for registration of securities under the Securities Act of 1933

Nov 19 19:21

SC 13G: Statement of acquisition of beneficial ownership by individuals-Anson Funds Management LP(9.9%),Anson Management GP LLC(9.9%), etc.

Nov 15 06:52

PRE 14A: Preliminary proxy statements relating to merger or acquisition

Nov 15 06:03

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bruce Grossman(Less than 1%)

Nov 14 05:20

8-K: Current report

Nov 14 00:27

8-K: Current report

Nov 8 05:38

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AMH Equity LLC(0.0%),Leviticus Partners, L.P.(0.0%)

Nov 7 23:13

D: Filing D

Nov 7 05:33

424B5: Prospectus

Oct 31 18:11

8-K: Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 31 18:06

SC 13G: Statement of acquisition of beneficial ownership by individuals-AMH Equity LLC(9.71%),Leviticus Partners, L.P.(9.71%)

Oct 3 04:39

8-K: Poll Results of 2024 Stockholders Meeting

Oct 1 04:53

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Oct 1 04:38

Applied DNA Sciences | 8-K: Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sep 18 21:07

DEFA14A: Others

Aug 21 21:50

DEF 14A: Definitive information statements

Aug 21 21:45

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AMH Equity LLC(0.00%),Leviticus Partners, L.P.(0.00%)

Aug 20 00:17

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AMH Equity LLC(8.41%),Leviticus Partners, L.P.(8.41%)

Aug 9 21:32

8-K: Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

Aug 9 04:21

10-Q: Q3 2024 Earnings Report

Aug 9 04:19